Tags

Type your tag names separated by a space and hit enter

Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region.
Int J Environ Res Public Health. 2022 09 25; 19(19)IJ

Abstract

Coronavirus disease (COVID-19) booster doses decrease infection transmission and disease severity. This study aimed to assess the acceptance of COVID-19 vaccine booster doses in low, middle, and high-income countries of the East Mediterranean Region (EMR) and its determinants using the health belief model (HBM). In addition, we aimed to identify the causes of booster dose rejection and the main source of information about vaccination. Using the snowball and convince sampling technique, a bilingual, self-administered, anonymous questionnaire was used to collect the data from 14 EMR countries through different social media platforms. Logistic regression analysis was used to estimate the key determinants that predict vaccination acceptance among respondents. Overall, 2327 participants responded to the questionnaire. In total, 1468 received compulsory doses of vaccination. Of them, 739 (50.3%) received booster doses and 387 (26.4%) were willing to get the COVID-19 vaccine booster doses. Vaccine booster dose acceptance rates in low, middle, and high-income countries were 73.4%, 67.9%, and 83.0%, respectively (p < 0.001). Participants who reported reliance on information about the COVID-19 vaccination from the Ministry of Health websites were more willing to accept booster doses (79.3% vs. 66.6%, p < 0.001). The leading causes behind booster dose rejection were the beliefs that booster doses have no benefit (48.35%) and have severe side effects (25.6%). Determinants of booster dose acceptance were age (odds ratio (OR) = 1.02, 95% confidence interval (CI): 1.01-1.03, p = 0.002), information provided by the Ministry of Health (OR = 3.40, 95% CI: 1.79-6.49, p = 0.015), perceived susceptibility to COVID-19 infection (OR = 1.88, 95% CI: 1.21-2.93, p = 0.005), perceived severity of COVID-19 (OR = 2.08, 95% CI: 137-3.16, p = 0.001), and perceived risk of side effects (OR = 0.25, 95% CI: 0.19-0.34, p < 0.001). Booster dose acceptance in EMR is relatively high. Interventions based on HBM may provide useful directions for policymakers to enhance the population's acceptance of booster vaccination.

Links

PMC Free PDF

Authors+Show Affiliations

Ghazy RM
Tropical Health Department, High Institute of Public Health, Alexandria University, Alexandria 21561, Egypt.
Abdou MS
Department of Epidemiology, High Institute of Public Health, Alexandria University, Alexandria 21561, Egypt.
Awaidy S
Health Affairs, Ministry of Health, Muscat 100, Oman.
Sallam M
Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan. Department of Clinical Laboratories and Forensic Medicine, Jordan University Hospital, Amman 11942, Jordan. Department of Translational Medicine, Faculty of Medicine, Lund University, 22184 Malmö, Sweden.
Elbarazi I
Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, AlAin 15551, United Arab Emirates.
Youssef N
Department of Medical-Surgical Nursing, College of Nursing, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
Fiidow OA
School of Public Health and Research, Somali National University, Mogadishu P.O. Box 15, Somalia.
Mehdad S
Physiology and Physiopathology Research Team, Research Centre of Human Pathology Genomics, Faculty of Sciences, Mohammed V University, Rabat BP 8007, Morocco.
Hussein MF
Occupational Health and Industrial Medicine Department, High Institute of Public Health, Alexandria University, Alexandria 21526, Egypt.
Adam MF
Faculty of Pharmacy, University of Science and Technology, Khartoum P.O. Box 12810, Sudan.
Abdullah FSA
Internal Medicine Department, Faculty of Medicine, Alexandria University, Alexandria 21526, Egypt.
Rebai WK
Institute Pasteur de Tunis, Tunis 2092, Tunisia.
Raad EB
Department of Epidemiology and Population Health, American University of Beirut, Beirut P.O. Box 110236, Lebanon. School of Pharmacy, Lebanese International University, Beirut P.O. Box 146404, Lebanon.
Hussein M
Clinical Research Administration, Alexandria Directorate of Health Affairs, Egyptian Ministry of Health and Population, Alexandria 21554, Egypt. Harvard Medical School, Boston, MA 02115, USA.
Shehata SF
Department of Family and Community Medicine, King Khalid University, Abha 62529, Saudi Arabia. Biostatistics Department, High Institute of Public Health, Alexandria University, Alexandria 21561, Egypt.
Ismail II
Department of Neurology, Ibn Sina Hospital, Gamal Abdel Nasser Street, Sabah Medical Area, Safat 070001, Kuwait.
Salam AA
National Institute of Health, Islamabad 45320, Pakistan.
Samhouri D
Emergency Preparedness and International Health Regulations, WHO EMRO (DS), P.O. Box 7608, Naser City 11371, Egypt.

MeSH

COVID-19COVID-19 VaccinesCross-Sectional StudiesDeveloped CountriesHealth Knowledge, Attitudes, PracticeHumansImmunization, SecondaryVaccination

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

36231447

Citation

Ghazy, Ramy Mohamed, et al. "Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: a Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region." International Journal of Environmental Research and Public Health, vol. 19, no. 19, 2022.
Ghazy RM, Abdou MS, Awaidy S, et al. Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region. Int J Environ Res Public Health. 2022;19(19).
Ghazy, R. M., Abdou, M. S., Awaidy, S., Sallam, M., Elbarazi, I., Youssef, N., Fiidow, O. A., Mehdad, S., Hussein, M. F., Adam, M. F., Abdullah, F. S. A., Rebai, W. K., Raad, E. B., Hussein, M., Shehata, S. F., Ismail, I. I., Salam, A. A., & Samhouri, D. (2022). Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region. International Journal of Environmental Research and Public Health, 19(19). https://doi.org/10.3390/ijerph191912136
Ghazy RM, et al. Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: a Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region. Int J Environ Res Public Health. 2022 09 25;19(19) PubMed PMID: 36231447.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region. AU - Ghazy,Ramy Mohamed, AU - Abdou,Marwa Shawky, AU - Awaidy,Salah, AU - Sallam,Malik, AU - Elbarazi,Iffat, AU - Youssef,Naglaa, AU - Fiidow,Osman Abubakar, AU - Mehdad,Slimane, AU - Hussein,Mohamed Fakhry, AU - Adam,Mohammed Fathelrahman, AU - Abdullah,Fatimah Saed Alabd, AU - Rebai,Wafa Kammoun, AU - Raad,Etwal Bou, AU - Hussein,Mai, AU - Shehata,Shehata F, AU - Ismail,Ismail Ibrahim, AU - Salam,Arslan Ahmed, AU - Samhouri,Dalia, Y1 - 2022/09/25/ PY - 2022/08/24/received PY - 2022/09/18/revised PY - 2022/09/20/accepted PY - 2022/10/14/entrez PY - 2022/10/15/pubmed PY - 2022/10/18/medline KW - COVID-19 vaccine KW - East Mediterranean region KW - booster dose acceptance KW - health belief model KW - vaccine hesitancy JF - International journal of environmental research and public health JO - Int J Environ Res Public Health VL - 19 IS - 19 N2 - Coronavirus disease (COVID-19) booster doses decrease infection transmission and disease severity. This study aimed to assess the acceptance of COVID-19 vaccine booster doses in low, middle, and high-income countries of the East Mediterranean Region (EMR) and its determinants using the health belief model (HBM). In addition, we aimed to identify the causes of booster dose rejection and the main source of information about vaccination. Using the snowball and convince sampling technique, a bilingual, self-administered, anonymous questionnaire was used to collect the data from 14 EMR countries through different social media platforms. Logistic regression analysis was used to estimate the key determinants that predict vaccination acceptance among respondents. Overall, 2327 participants responded to the questionnaire. In total, 1468 received compulsory doses of vaccination. Of them, 739 (50.3%) received booster doses and 387 (26.4%) were willing to get the COVID-19 vaccine booster doses. Vaccine booster dose acceptance rates in low, middle, and high-income countries were 73.4%, 67.9%, and 83.0%, respectively (p < 0.001). Participants who reported reliance on information about the COVID-19 vaccination from the Ministry of Health websites were more willing to accept booster doses (79.3% vs. 66.6%, p < 0.001). The leading causes behind booster dose rejection were the beliefs that booster doses have no benefit (48.35%) and have severe side effects (25.6%). Determinants of booster dose acceptance were age (odds ratio (OR) = 1.02, 95% confidence interval (CI): 1.01-1.03, p = 0.002), information provided by the Ministry of Health (OR = 3.40, 95% CI: 1.79-6.49, p = 0.015), perceived susceptibility to COVID-19 infection (OR = 1.88, 95% CI: 1.21-2.93, p = 0.005), perceived severity of COVID-19 (OR = 2.08, 95% CI: 137-3.16, p = 0.001), and perceived risk of side effects (OR = 0.25, 95% CI: 0.19-0.34, p < 0.001). Booster dose acceptance in EMR is relatively high. Interventions based on HBM may provide useful directions for policymakers to enhance the population's acceptance of booster vaccination. SN - 1660-4601 UR - https://www.unboundmedicine.com/medline/citation/36231447/Acceptance_of_COVID_19_Vaccine_Booster_Doses_Using_the_Health_Belief_Model:_A_Cross_Sectional_Study_in_Low_Middle__and_High_Income_Countries_of_the_East_Mediterranean_Region_ DB - PRIME DP - Unbound Medicine ER -